Del Rosario, Joanne Marie M., Vishwanath, Sneha, Frost, Simon D.W., Sujit, Sneha B., Ashokan, Sruthika K., Vendramelli, Robert, Ferrari, Matteo, Carnell, George W., Vianello, Lucrezia, Pagliari, Matteo, and others. (2026) Broad vaccine protection against globally diverse influenza A/H5Nx viruses. Cell Reports Medicine, . Article Number 103131. ISSN 2666-3791. (doi:10.1016/j.xcrm.2026.103131) (KAR id:117574)
|
PDF
Publisher pdf
Language: English
This work is licensed under a Creative Commons Attribution 4.0 International License.
|
|
|
Download this file (PDF/8MB) |
Preview |
| Request a format suitable for use with assistive technology e.g. a screenreader | |
| Official URL: https://doi.org/10.1016/j.xcrm.2026.103131 |
|
Abstract
Influenza A/H5Nx viruses continue to diversify and undergo gene reassortment as they infect avian and mammalian hosts worldwide. The severity of human infections varies substantially between different H5 clades and neuraminidase (NA) reassortants, creating unpredictable pandemic risk. Existing H5 vaccines, typically based on a single hemagglutinin (HA) strain, cannot keep pace with this natural variation. To address this problem, we computationally engineer HA, NA, and M2 antigens representing the global antigenic space of circulating H5Nx viruses, prioritizing N1 and N6 subtypes associated with the highest threat in humans. The resulting digitally immune-optimized mRNA vaccine, DVX-panH5Nx, elicits broad HA neutralization and NA inhibition across divergent clades in mice and ferrets. Compared to WHO candidate vaccine viruses (CVVs), DVX-panH5Nx confers superior protection against antigenically distinct H5N1 challenges spanning two decades of viral evolution, demonstrating that computationally designed multivalent antigen vaccines can overcome natural influenza diversification and provide a scalable strategy for pre-pandemic preparedness.
| Item Type: | Article |
|---|---|
| DOI/Identification number: | 10.1016/j.xcrm.2026.103131 |
| Subjects: | Q Science > QR Microbiology > QR355 Virology |
| Institutional Unit: | Schools > Medway School of Pharmacy |
| Former Institutional Unit: |
There are no former institutional units.
|
| Funders: |
Bill & Melinda Gates Foundation (https://ror.org/0456r8d26)
Innovate UK (https://ror.org/05ar5fy68) |
| Depositing User: | Nigel Temperton |
| Date Deposited: | 06 Nov 2026 19:00 UTC |
| Last Modified: | 09 Nov 2026 17:11 UTC |
| Resource URI: | https://kar.kent.ac.uk/id/eprint/117574 (The current URI for this page, for reference purposes) |
- Link to SensusAccess
- Export to:
- RefWorks
- EPrints3 XML
- BibTeX
- CSV
- Depositors only (login required):

https://orcid.org/0000-0002-7978-3815
Altmetric
Altmetric